June 15 -16, 2021 | VIRTUAL EVENT

AGENDA – ALL TIMES ARE IN EASTERN TIME

Speakers will be available for Q&A and further dialogue within their respective ‘Meet The Speaker’ Break Out Roundtables: A safe space to talk candidly through your challenges, new tools/tactics. Dedicated VIDEO Q&A time, not only with the speaker, but with your industry peers. This is not a live chat or faceless group. This is an opportunity to have an engaged conversation with your industry counterparts. The speaker may have questions for you!

Paul Ivans
Founder and CEO
EVOLUTION ROAD
Todd Kolm Conference Co-Chair
Practice Leader, Digital Health and Innovation R&D
EVOLUTION ROAD
  • What are the key healthcare dynamics that are changing the life science commercial landscape?
  • What impacts are life science leaders seeing coming over the horizon to their current commercial models?
  • How can digital health serve as a strategic imperative to address these changes and challenges?
  • How should marketers be thinking about digital health opportunities as they shape their brand plans?
  • What are the largest short and long-term areas of digital health opportunity for life science commercial teams
Moderator:

Kate Miller
Principal, Practice Lead Digital Innovation
EVOLUTION ROAD

Panelists:

Sharon DeBacco
Vice President, Product Promotion and Communication
IRONWOOD PHARMACEUTICALS

Brenda Raphael
Former Vice President, New Products and Launch Excellence
NOVARTIS

Francesca Wuttke
Chief Digital Officer
ALMIRALL

Interactive live polling available to interact with both the experts and attendees

  • Learn from a patient marketing pioneer who’s spent the last decade innovating patient marketing with the new opportunities created by digital health
  • Understand why the traditional approach to patient marketing is becoming outdated as care moves from hospitals and physician’s offices and closer to the patient
  • Learn how to approach understand the new patient journey centered around care anywhere and anytime, unlocked by the vast array of new digital health innovations
  • Understand emerging practices that broaden the lens of patient engagement and support to go far beyond traditional digital strategies and channels
Christine Sakdalan
Head of Franchise Strategy and Customer Solutions
JANSSEN NEUROSCIENCE
Hans Kaspersetz
CEO
ARTERIC
Learn how industry pioneers are helping their organizations understand the Social Determinants of Health landscape, integrate Social Determinants into commercial efforts and execute to make a significant and lasting impact on traditionally underserved patient communities

  • Connecting SDoH with your organization’s broader goals and strategic initiatives
  • Understanding the important dynamics and nuances of the SDoH landscape
  • Recognizing the importance of Data, Partnerships and Policy in advancing SDoH within your organization
  • Operationalizing SDoH efforts across your life science organization so it becomes an integral component of the core business
  • Understanding alternative ways that Digital Health can help close (vs. broaden) the Health Equity Gap
Panelists:

Conrod Kelly
Executive Director, Global Health Equity, US Marketing
MERCK
  • Request 1:1 peer meetings, with video and voice call capabilities to replicate the live event onsite experience of sharing challenges, solutions and partner evaluations
  • Visit Virtual Booths and have live video demonstrations/voice calls of pivot solutions to navigate the current uncertainty
  • Simply exchange thoughts with your peers in the live chat
Meet the Speaker Roundtable

A safe space to talk candidly through your challenges, new tools/tactics. Dedicated VIDEO Q&A time, not only with the speaker, but with your industry peers. This is not a live chat or faceless group. This is an opportunity to have a face-to-face,engaged conversation with your industry counterparts. The speaker may have questions for you!

Paul Ivans
Founder and CEO
EVOLUTION ROAD

Todd Kolm
Practice Leader, Digital Health and Innovation
EVOLUTION ROAD

Kate Miller
Principal, Practice Lead Digital Innovation
EVOLUTION ROAD

Sharon DeBacco
Vice President, Product Promotion and Communication
IRONWOOD PHARMACEUTICALS

Brenda Raphael
Former Vice President, New Products and Launch Excellence
NOVARTIS

Francesca Wuttke
Chief Digital Officer
ALMIRALL

Hans Kaspersetz
CEO
ARTERIC

Christine Sakdalan
Head of Franchise Strategy and Customer Solutions
JANSSEN NEUROSCIENCE
  • Taking patient insights and using these to generate predictors of value
  • Leveraging digital health as a way to generate better insights and support patients and HCPs
  • Executing on commercial transformation: what to take into account; from R&D to the interface with patients and HCPs in commercial
Rachel Sha
Vice President, Digital Strategy and Governance
SANOFI
  • Implementing change management with the leadership
  • Creating a foundation of governance to clearly articulate process
  • How do you frame success?
  • Onboarding stakeholders to set them up for success
  • How do you select the right partners?
Panelists:

Amy West
Head of US Digital Health and Innovation Strategy
NOVO NORDISK

Sai Rangarao
Vice President and Head of Marketing
BIODELIVERY SCIENCES INTERNATIONAL

Interactive live polling available to interact with both the experts and attendees

Mimi Huizinga
Vice President and Head US Oncology Medical
NOVARTIS
A safe space to talk candidly through your challenges, new tools/tactics. Dedicated VIDEO Q&A time, not only with the speaker, but with your industry peers. This is not a live chat or faceless group. This is an opportunity to have a face-to-face,engaged conversation with your industry counterparts. The speaker may have questions for you!

Amy West
Head of US Digital Health and Innovation Strategy
NOVO NORDISK

Mimi Huizinga
Vice President and Head US Oncology Medical
NOVARTIS

Rachel Sha
Vice President, Digital Strategy and Governance
SANOFI

Melinda Decker
Chief Commercial Officer
MYMEE

Sai Rangarao
Vice President and Head of Marketing
BIODELIVERY SCIENCES INTERNATIONAL
  • Translating technology to business value
  • Examining the business value and business case for technology innovation
  • Evaluating the value proposition for Digital Therapeutics
  • Reimbursement: relocating reimbursement as part of the innovation process. What is the value proposition of tech and what is the willingness to pay?
  • Change management/digital transformation considerations both short and long term
Stephen Ranjan
Vice President, Franchise Lead Professional and Non-Insulin Therapy Solutions, Strategy and Customer Solutions
ROCHE DIABETES CARE
Chris DiCostanzo
Vice President Patient Engagement
OPTIMIZERX
  • How digital health has evolved through digital transformation to a rapid acceleration in 2020 and beyond
  • Why silos mattered, and why it's time to remove them
  • Integration Digital Health pilots, marketing insights (classic pharma marketing) and innovation - what 2020 revealed
  • Integration in the future - commercially supported through leadership vision and action
Jian Yang
Senior Director, Digital Health
ELI LILLY
A safe space to talk candidly through your challenges, new tools/tactics. Dedicated VIDEO Q&A time, not only with the speaker, but with your industry peers. This is not a live chat or faceless group. This is an opportunity to have a face-to-face,engaged conversation with your industry counterparts. The speaker may have questions for you!

Stephen Ranjan
Vice President, Franchise Lead Professional and Non-Insulin Therapy Solutions, Strategy and Customer Solutions
ROCHE DIABETES CARE

Jian Yang
Senior Director, Digital Health
ELI LILLY

Chris DiCostanzo
Vice President Patient Engagement
OPTIMIZERX
Paul Ivans
Founder and CEO
EVOLUTION ROAD

Speakers will be available for Q&A and further dialogue within their respective ‘Meet The Speaker’ Break Out Roundtables: A safe space to talk candidly through your challenges, new tools/tactics. Dedicated VIDEO Q&A time, not only with the speaker, but with your industry peers. This is not a live chat or faceless group. This is an opportunity to have an engaged conversation with your industry counterparts. The speaker may have questions for you!

  • Framing the ‘need’ question
  • Proximity to the ‘wrong’ patients
  • New findings that don’t come a prior
  • Can we predict….with confidence?
Mark Milton-Edwards
Head of Health Solutions, Digital Health
TEVA PHARMACEUTICALS
  • Explore Amazon’s innovation culture and how Amazon Web Services (AWS) supports the life science industry
  • Highlight key commercial life science trends and AWS partner use cases
  • Share customer success stories in digital health across patient engagement, digital therapeutics, digital biomarkers, and real world data insights
Larry Brooks
Global Alliances Manager - HCLS
AMAZON WEB SERVICES
Moderator:

Shwen Gwee
Vice President and Head of Global Digital Strategy
BRISTOL MYERS SQUIBB

Panelists:

Rohit Bansal
US Commercial Lead - Digital Therapeutics
OTSUKA PHARMACEUTICALS

Interactive live polling available to interact with both the experts and attendees

  • Request 1:1 peer meetings, with video and voice call capabilities to replicate the live event onsite experience of sharing challenges, solutions and partner evaluations
  • 1:1 AU based matchmaking
  • Visit Virtual Booths and have live video demonstrations of solutions to navigate the current uncertainty
  • Simply exchange thoughts with your peers in interactive networking roundtaless
Meet the Speaker Roundtables

A safe space to talk candidly through your challenges, new tools/tactics. Dedicated VIDEO Q&A time, not only with the speaker, but with your industry peers. This is not a live chat or faceless group. This is an opportunity to have a face-to-face,engaged conversation with your industry counterparts. The speaker may have questions for you!

Aya Caldwell
Executive Director Digital Products, Novartis Group Digital Office
NOVARTIS

Shwen Gwee
Vice President and Head of Global Digital Strategy
BRISTOL MYERS SQUIBB

Rohit Bansal
US Commercial Lead - Digital Therapeutics
OTSUKA PHARMACEUTICALS

Mark Milton-Edwards
Head of Health Solutions, Digital Health
TEVA PHARMACEUTICALS

Larry Brooks
Global Alliances Manager - HCLS
AMAZON WEB SERVICES
  • What are the areas of opportunities for pharma-digital health partnerships (partner vs. build)?
  • What has been COVID-19’s impact on pharma digital innovation or digital health?
  • What are the key success factors of a pharma-digital health partnership?
  • What are some of the watch-outs/common challenges in a pharma-digital health partnership?
  • How can a pharma company get ready for digital innovation and partnerships (e.g., culture, organization structures, leadership endorsement)?
Lauren Li
Head of Digital Health
IPSEN
  • Request 1:1 peer meetings, with video and voice call capabilities to replicate the live event onsite experience of sharing challenges, solutions and partner evaluations
  • 1:1 AU based matchmaking
  • Visit Virtual Booths and have live video demonstrations of solutions to navigate the current uncertainty
  • Simply exchange thoughts with your peers in interactive networking roundtaless
Meet the Speaker Roundtables

A safe space to talk candidly through your challenges, new tools/tactics. Dedicated VIDEO Q&A time, not only with the speaker, but with your industry peers. This is not a live chat or faceless group. This is an opportunity to have a face-to-face,engaged conversation with your industry counterparts. The speaker may have questions for you!

Meghan Rivera
Chief Marketing Officer and Head of Commercial
AKILI INTERACTIVE

Lauren Li
Head of Digital Health
IPSEN
  • Learn about the importance of behavioral health in driving outcomes for physical and mental health conditions
  • Develop a deeper understanding of the nuances and types of behavioral health strategies and approaches
  • Learn how life science brand teams can harness digital behavioral health to make a difference, drive better patient outcomes, and support the needs of providers across the care continuum
  • Understand the role that digital plays in identification of behavioral health risk, targeting treatment and demonstrating real world efficacy of solutions
  • Hear case examples of how behavioral health is being applied by brands across the life sciences
Arun Bhatia
Open Innovation and Startup Engagement Lead
ROCHE DIABETES CARE

Monique Levy
Chief Commercial and Strategy Officer
WOEBOT HEALTH

Kate Wolin
Co-Founder
CIRCEA
Ryan Sysko
CEO
AMALGAMRX
  • Discuss a pharma strategy to identify and address gaps in care across populations through Digital Health collaborations
  • Share how digital health is being applied to the Merck US Market
  • Discuss best practices and key capabilities in implementing digital health that can be applied across pharma
Moderator:

Alvaro Luna
Associate Principal
EVOLUTION ROAD

Interviewee:

Bryan Mallitz
Executive Director, Digital Health Alliances, US Market
MERCK
A safe space to talk candidly through your challenges, new tools/tactics. Dedicated VIDEO Q&A time, not only with the speaker, but with your industry peers. This is not a live chat or faceless group. This is an opportunity to have a face-to-face,engaged conversation with your industry counterparts. The speaker may have questions for you!

Bryan Mallitz
Executive Director, Digital Health Alliances, US Market
MERCK

Alvaro Luna
Associate Principal
EVOLUTION ROAD

Arun Bhatia
Open Innovation and Startup Engagement Lead
ROCHE DIABETES CARE

Monique Levy
Chief Commercial and Strategy Officer
WOEBOT HEALTH

Kate Wolin
Co-Founder
CIRCEA
  • Defining SaMD; a foundation to understanding SaMD
  • The SaMD regulatory landscape; US/EU/Global. Current regulations, guidances, and the evolving regulatory landscape
  • Development of SaMD; best practices for commercial success and improving patient health outcomes
  • Case studies: Is your software a medical device? Assessing SaMD vs Non-SaMD; key aspects for determination
  • Cybersecurity and safety concerns; Post-market support
George Cusatis
Director, Device and Digital Health
MERCK
  • Meet pharma marketers who introduced telehealth into their integrated brand strategies
  • Meet telehealth vendors who partnered with pharma marketers to navigate the legal and regulatory landscape to achieve outcomes in telehealth
  • Gain transferable lessons on:
    • How success was defined, measured and achieved
    • How barriers were encountered and overcome
  • Understand what comes next as strategies and capabilities evolve
Panelists:

Josie Waters
Senior Director, Consumer Marketing
IRONWOOD PHARMACEUTICALS

Alexia Burnett Salinas
Group Product Director, Customer Solutions, Neuroscience
JOHNSON & JOHNSON

Lisa Podhayny
Director, Marketing, PR and Corporate Communications
BIODELIVERY SCIENCES INTERNATIONAL

Dennis Snyder
Chief Marketing Officer
UPSCRIPTHEALTH
  • Discus machine intelligence strategies and novel approaches like ClinicalTrials2Vec
  • Leverage clinical trial big data and machine intelligence to improve drug development
  • Clinical trial data repositories plays an important role in improving the trials of the future
  • Demonstrate the use of several clinical trial resources and its utility in developing predictive models to improve trials
Shaheem Khadeer
Senior Director (Data Science, AI/ML, Digital Health & Bioinformatics)
ASTRAZENECA
Shaheem Khadeer
Senior Director (Data Science, AI/ML, Digital Health & Bioinformatics)
ASTRAZENECA

Josie Waters
Senior Director, Consumer Marketing
IRONWOOD PHARMACEUTICALS

George Cusatis
Director, Device and Digital Health
MERCK

Alexia Burnett Salinas
Group Product Director, Customer Solutions, Neuroscience
JOHNSON & JOHNSON

Lisa Podhayny
Director, Marketing, PR and Corporate Communications
BIODELIVERY SCIENCES INTERNATIONAL

Dennis Snyder
Chief Marketing Officer
UPSCRIPTHEALTH
Todd Kolm
Practice Leader, Digital Health and Innovation
EVOLUTION ROAD

Continue the dialogue far into the future by joining our LinkedIn Group: https://www.linkedin.com/groups/101428/